The crystal structure of mature Polygonatum cyrtonema lectin (PCL) showed three similar carbohydrate-binding sites (CBS I, CBS II, and CBS III). The Gln58 and Asp60 residues of CBS II are substituted with His58 and Asn60. To establish the relationship between the key amino acid residues and structure or activity of PCL, we constructed four recombinant mutants in CBS I, CBS II, and CBS III. The experimental results indicate that CBS I, CBS III and the disulfide bond play vital roles in the binding with mannose. Furthermore, molecular dynamics simulations and binding free energy calculation illustrate that CBS I has a direct and strong relationship with the activity of PCL. CBS II does not play a critical role in the model for mannose binding by PCL. Although CBS III does not enhance the activity, it helps to maintain the activity and 3D structure. These results suggest that the carbohydrate-binding site of PCL may be in a hydrophilic environment, and Asn and Tyr are the key amino acids involved in its binding with sugar, but Gln and Asp are not necessary to maintain its activity.
Introduction
Lectins are carbohydrate-binding proteins or glycoproteins that can specifically recognize and bind to monosaccharides or oligosaccharides of glycoproteins and agglutinate red blood cells, lymphocytes, fibroblasts, etc. [1, 2] . As nonimmune origin specific carbohydratebinding proteins, lectins are widely distributed in all the kingdoms of biological world and play important roles in organisms. In particular, plants contain lectins that exhibit several potential biological activities, including anti-insect [3] , antifungal [4] , antibacterial [5, 6] , antitumor [7, 8] , and antivirus activities [9] [10] [11] . All these bioactivities of plant lectins are strongly associated with their carbohydratespecific binding activity [12] .
The monocot mannose binding lectin (MBL), a representative family in plant lectins, was renamed as GNA-related lectin [13] . MBLs have received an increasing attention because of their specific and strong inhibition to human and animal retroviruses, such as HIV. They also have great potential application in cancer therapy. A common subunit with β-prism II fold exists in the GNA-related lectins, and the β-prism II fold has three carbohydrate-binding sites (CBSs) with conserved amino acids of 'QXDXNXVXY' essential in mannose recognition [7, 14] . The biological activities of GNArelated lectins are closely correlate with their respective structures [10] . Polygonatum cyrtonema lectin (PCL) [15] [16] [17] , GNA [18] , Ophiopogon japonicus lectin (OJL) [19] , and Polygonatum odoratum lectin (POL) [20] belong to the GNA-related lectin family.
PCL is a member of GNA-related lectin family. It was purified from the rhizomes of Polygonatum cyrtonema Hua, a traditional Chinese medicinal herb from Liliaceae [21, 22] . It shows great inhibitory activity on tumor cells and viruses, but does not harm humans and animals. Gene cloning, amino acid sequence analysis, and 3D structure showed that mature PCL has three similar CBSs (CBS I, CBS II, and CBS III). However, only CBS I and CBS III have a conserved carbohydrate-binding motif of QXDXNXVXY (X is one of the amino acid residues), as observed in other structurally characterized GNA-related lectins. PCL can specifically bind to mannose, and the amino acid residues of CBSs of PCL are Gln, Asp, Asn, and Tyr, which bind to the O2, O3, and O4 of mannose through a network of hydrogen bonds. Many auxiliary interactions contribute to the stabilization of mannose including nonpolar van der Waals interactions, and extensive tacking interactions. CBS II motif is 'HXNXNXVXY', and the critical residues Gln58 and Asp60 of CBS II are substituted with His58 and Asn60 [17] . Because of these substitutions, the hydrogen bonds formed between mannose and CBS II vanished. CBS II is unfit for mannose-binding but may bind other types of sugars such as sialic acid [23] . Hence, the mannose affinity of PCL was lower than that of GNA and other mannose-binding lectins whose mannose-binding site did not mutate, such as NHA and CMA.
In a pioneering work, in order to analyze the site of sugar-binding and modify the specificity, site-directed mutagenesis of lectins has been attempted. van Eijsden et al. [24] used mutational analysis of pea lectin to determine the effect of central area and adjacent residues of the sugar-binding site on its hemagglutination activity. The N125D mutation resulted in complete loss of sugar-binding activity of Pisum sativum lectin (PSL). However, substitution of an adjacent residue, A126V, did not have any detectable influence on sugar-binding activity. The study demonstrated the essential residues and dispensable residues of PSL in sugar binding. Sharon's group [25] used site-directed mutagenesis to increase the affinity of Erythrina corallodendron lectin towards galactose derivatives with bulky substituents at C2. They also mimicked the binding site of Peanut agglutinin (PNA) and studied their specificity. Similarly, the specificity of the lima bean lectin, a galactose-specific legume lectin, was explored and the C127Y mutant was found to have a higher affinity for the type-A trisaccharide than the wild-type [26] . Nishiguchi et al. [27] elucidated the mechanism of the binding of carbohydrate of Robinia pseudoacacia lectin (RBL) by means of site-directed mutagenesis. It seems probable that Asp87 plays an essential role in the binding of RBL with carbohydrate, and both the negative charge and the length of the side chain of aspartic acid are important for the interaction of such lectins with carbohydrates. Tateno et al. [28] investigated the structure-function relationship of the Polyporus squamosus lectin (PSL) using PSL mutants. The results indicated that the carbohydratebinding sites are situated in the N-terminal portion of the lectin, whereas the C-terminal portion probably functions in oligomerization and structural stabilization. Simultaneously, the β and γ subdomains are most probably the sugar-binding sites [28] . Maenuma et al. [29] prepared a library of 35 variants in the carbohydrate-recognition domain of Maackia amurensis hemagglutinin (MAH). The library of mutated MAH is useful for the profiling of various cells based on the variations of surface glycans. The site-directed mutagenesis was also used to alter the valency of oligomeric lectins in order to improve their affinities toward carbohydrates. Olausson et al. [30] prepared a monomeric form of Aleuria aurantia lectin (AAL) that is normally found as a homodimer. A 20-fold higher concentration of mAAL was needed to induce hemagglutination when compared with the wild-type. This difference is most likely explained by a higher availability of binding sites in the dimeric form compared with the monomeric form of AAL.
However, at the present, no attempt has been made to reveal the detailed structure of lectins and the interaction with the carbohydrate ligand, especially the MBLs of plant lectins, which is a prerequisite for a better understanding of the biological and physical processes of plant lectins.
Although the structure and function of PCL have been preliminarily studied, more extensive structure-function data are needed to gain deeper insights into the structural mechanism of PCL. The structure-function of MBLs' ramification can also be supplemented with these data.
In this study, we not only constructed the site-directed mutants of disulfide bonds and amino acids located in the CBSs of PCL to investigate the relationship between mutation sites and agglutination activity, but also used bioinformatics methods to simulate the structural change and carbohydrate-binding strength of mutants. Then, the comparison of the structural stability and biological activity of mutants with those of the wild-type rPCL revealed the function of each individual carbohydrate-binding domain on the structure and activity of PCL. Moreover, we determined the key amino acids that directly affect the structural stability and biological activity of PCL. The interaction between carbohydrates and proteins were further revealed through bioinformatics, biochemistry, and molecular biology techniques.
Materials and Methods

Plant materials
Polygonatum cyrtonema Hua was purchased from a Chinese herbal medicine planting professional cooperative in Changning County (Yibin, China)
Chemicals and reagents
pET-32a(+) expression vector and Escherichia coli BL21 (DE3) cells were obtained from Novagene (Gibbstown, USA). E. coli strains were obtained from Invitrogen (Carlsbad, USA). UNIQ-10 column Trizol total RNA extraction Kit was purchased from Sangon Biotechnology (Shanghai, China). Restriction enzymes, Ex Taq polymerase, Reverse Transcription Kit, One Step RNA PCR Kit (AMV), MutanBEST Kit and DNA marker DL2000 were purchased from TaKaRa (Dalian, China). E.Z.N.A. Gel Extraction Kit, E.Z.N.A. Cycle-Pure Kit and E.Z.N.A. Plasmid Miniprep Kit were obtained from Omega (Norcross, USA). Fresh rabbit blood was obtained from the local market. Ni 2+ -chelating Sepharose FF, CM-Sepharose FF and Sephadex G-25 were purchased from Pharmacia (Uppsala, Sweden). Mannan, galnac, mannose, galactose, fructose, n-acetyl, glucosamine, and thyroglobulin were purchased from Sigma (St Louis, USA). All other chemicals used in this study were of the highest purity available.
RNA isolation and cDNA synthesis
Total RNA was isolated using UNIQ-10 column Trizol total RNA extraction Kit from the fresh rhizomes of Polygonatum cyrtonema Hua. The cDNA was reversely transcribed using the Reverse Transcription Kit. According to PCL full-length cDNA gene sequence (GenBank accession: AY099150) and plasmid vector pET32-a(+), the primers (PE1:5′-AAAGGATCCGACGACGACGA CAAGGTCAATTCTCTGT-3′) and (PE2:5′-GCGAAGCTTTTATT AGGCCGGTCCAGAGCCTGTGGC-3′) were designed to amplify the PCL mature peptide fragments of DNA. The PCR products were digested with BamHI and HindIII, then they were ligated into the pET-32a(+) vector extracted from E. coli DH5α. The ligated vector pET-32a(+)-PCL was transformed into E. coli JM109, and then the transformed cells were used to purify the plasmid using the E.Z.N.A. Plasmid Miniprep Kit. The DNA sequence was verified by sequencing.
Selection of the mutagenesis site
For the rational design of mutagenesis site, the amino acid sequences of PCL and related lectins were collected from NCBI (https://www.ncbi.nlm.nih.gov/) and aligned using the MEGA6 to find a conservative sequence in PCL compared with other MBLs. The structures and conservative areas were analyzed as reported in a previous study [23] . In order to investigate the effect of the originally mutated residues in CBS II and conservative residues in CBS I and CBS III of PCL compared with other lectins, we designed the same mutagenesis sites on the basis of the conservative sequence of the alignment in PCL. Additionally, we also constructed the disulfide bond mutant to investigate the effect of the disulfide bond on the structure of PCL.
Construction of the expression system for rPCL and its mutants
Site-directed mutagenesis was achieved through PCR using the MutanBEST Kit (TaKaRa) according to the manufacturer's instructions. The purified plasmid pET-32a(+)-wPCL obtained in the previous step was used as the template, and the mutagenesis primers were synthesized as shown in Supplementary Table S1 . The construct pET-32a(+)-mPCL plasmids were transformed into E. coli JM109. The mutational plasmids were purified using the E.Z.N.A. Plasmid Miniprep Kit. E. coli BL21 (DE3) harboring the mutational plasmids were grown in LB plates containing 50 μg/ml of ampicillin and 1 mM of isopropyl-β-D-1-thiogalactopyranoside (IPTG) and incubated at 37°C overnight. Anti-His antibody was used to verify the expression products by western blot analysis. The positive clones were confirmed by digesting with restriction enzyme and PCR. The gene sequence was verified by sequence analysis.
Optimization of expression conditions
Several positive clones of E. coli BL21 (DE3) with pET-32a (+)-wPCL and pET-32a(+)-mPCL transformants were selected and cultured in 5 ml LB medium with 50 μg/ml ampicillin. Different OD 600 (0.2, 0.4, 0.6, 0.8, 1.0, and 1.2) and final concentrations of IPTG (0.1, 0.3, 0.5, and 1 mM) were tested, and the incubation time was 3 h. Simultaneously, the subcultures were incubated at different temperatures (18°C, 25°C, 30°C, and 37°C) for an additional 3 h after the addition of IPTG. In addition, the subcultures were incubated in mediums of diverse pH (6.0, 6.6, 7.2, 7.6, and 8.0) for 3 h. Ten microliters of each resuspended cell culture were used for SDS-PAGE and thin-layer scanning analysis.
Purification of the fusion wrPCL and mrPCL
After the optimization of the expression conditions of wild-type rPCL (wrPCL) and mutant rPCL (mrPCL), 1 ml of culture was collected as the control group before induction. The rest of cells was resuspended in an extraction buffer (10 mM PB, 10 mM imidazole, 0.5 M NaCl, pH 8.0), and then disrupted by high-pressure homogenization on ice for three times. The lysate was centrifuged at 9000 g for 30 min at 4°C to remove debris, a part of supernatant with 2× SDS loading buffer was analyzed by 15% SDS-PAGE. Another part of the soluble proteins was purified by affinity chromatography using Ni
2+
-chelating Sepharose FF according to the manufacturer's instruction at a flow rate of 2 ml/min. The pH of the supernatant was adjusted to 8, and the Ni 2+ -chelating Sepharose FF column was equilibrated with three column volume of binding buffer (10 mM PB, 10 mM imidazole, 0.5 M NaCl, pH 8.0) before the soluble proteins were loaded on the column. The bound protein was recovered by stepwise elution with 25, 50, 100, and 200 mM imidazole in the binding buffer. The eluents were analyzed by 15% SDS-PAGE.
Enzymatic cleavage and secondary purification
The imidazole concentration was adjusted to 20 mM with cleavage buffer (500 mM Tris-HCl, 10 mM CaCl 2 , 1% Tween-20, pH 8.0) before the cleavage of proteases. The purified fusion proteins were incubated with enterokinase for 12 h at 37°C. The digested mixture was loaded on the Ni 2+ -chelating Sepharose FF to remove the impurities. The final product was dialyzed against the loading buffer (20 mM HAc-NaAc, pH 5.0) extensively and loaded on a CMSepharose FF column equilibrated with the loading buffer at a flow rate of 2 ml/min. The bound protein was eluted with the elution buffer (20 mM HAc-NaAc, 0-1 M NaCl, pH 5.0) at a flow rate of 2 ml/min. The eluents were collected, and the activity was measured by hemagglutination assay. After desalting with a Sephadex G-25 column, the active fractions were pooled and lyophilized. The purity of the samples was analyzed by 15% SDS-PAGE. Protein concentration was determined by Lowry method [31] using BSA as the standard.
Hemagglutination assay
The hemagglutinating activities of the purified wrPCL and mutants were assayed by the serial-dilution method in microtiter plates using 2% rabbit erythrocytes prepared from fresh rabbit bood. The dry powder of wrPCL and mutant was dissolved in physiological saline. Two-fold serial dilutions of 25 μl of the samples in physiological saline were incubated with 25 μl of erythrocytes in a 96-well microtiter U-plate for 1 h at 25°C. Agglutination was assessed under a microscope [32, 33] .
To determine the effect of temperature on hemagglutinating activity, a solution of the purified samples of wrPCL and mrPCL was heated at various temperature including 20°C, 40°C, 60°C, 70°C, and 80°C for 20 min. Then, they were cooled to room temperature immediately. The agglutination of samples was assessed by the hemagglutination assay as described above [34, 35] To determine the effect of pH on hemagglutinating activity, the purified samples were incubated for 15 min in buffers of various pH from 2 to 12. These buffers included KCl-HCl buffer (pH 2.0), citric acid-sodium citrate buffer (pH 3.0-5.0), phosphate buffer (pH 6.0-7.0), sodium carbonate/bicarbonate buffer (pH 8.0-11.0), and KCl-NaOH buffer (pH 12.0). The agglutination of samples was then assessed by the hemagglutination assay.
Hemagglutination inhibition assay
The hemagglutination inhibition was tested as described by Li et al. [32] . The carbohydrates tested include mannan, thyroglobulin, D-mannose, D-galactose, D-fructose, n-acetyl and D-glucosamine. Inhibition of hemagglutinating activity was assessed under a microscope.
Endogenous fluorescence spectroscopy
All the fluorescence spectra of the wrPCL and mrPCL were measured by using a HITACHI F-4500 fluorescence spectrophotometer (Model 4500; Hitachi, Tokyo, Japan). The samples were excited at 295 nm. The concentration of samples was 0.1 mg/ml, and the spectral width of the emission spectrum was 5 nm with a scanning speed of 180 nm/min [36] .
Molecular docking
The structures of wild-type rPCL (PDB code: 3A0D) were obtained from the RCSB protein databank. The UCSF chimera program [37] and 2DGraLab program [38] were used to generate and optimize the complex structure of PCL mutations. Docking calculations were performed using the AutoDock program [39] . Here, a blind docking was performed to identify the preferential binding area. A grid box of 45 × 45 × 45 points with a grid spacing of 0.418 Å was calculated for proper atom types and centered at the interface to cover the catalytic sites.
Classical molecular dynamic simulations and binding free energy calculation
Here, molecular dynamics (MD) simulation was performed using the GROMACS 5.0 program [40] to investigate the stability of the ligand-receptor complexes. The simulation systems consisted of: (i) the ligand-receptor complex which was solved using TIP3P water molecules [41] , (ii) Na + and Cl − ions at 0.15 M which were used to neutralize the system, and (iii) periodic boundary conditions with a dodecahedron periodic box which was set at a minimal distance of 1.0 nm. First, the receptor topology files were converted using the pdb2gmx program of the GROMACS package with parameters taken from AMBERff99SB force field [42] . Then, the ligand topology file was converted using the antechamber program of AmberTools [43] with parameters taken from a general amber force field (GAFF) [44] . After that, the system was subject to two phases of equilibration for a period of 1 ns at constant temperature (300 K) along with constant pressure (1 atm). The two phases consisted of NVT (constant number of particles, volume, and temperature) and NPT (constant number of particles, pressure, and temperature) equilibration, respectively. Then, MD simulations with a time step of 2 femtoseconds (fs) at constant pressure and temperature were performed. The covalent bond lengths were constrained using linear constraint solver algorithm [45] and long-range electrostatic interactions were calculated using the particle mesh Ewald (PME) method [46] . Finally, MD simulations for all systems were performed for 30 ns to analyze the binding affinity of mutation-drug system. In addition, trajectory information was collected every 2 fs for further analysis. Furthermore, the MM-PBSA method was used to calculate the relative binding free energy (ΔGbind) between the PCL and monomannoside. The energy components of each complex were calculated using the snapshots extracted every 2 fs from the production trajectories of MD simulation. The detailed parameters were reported in our previous studies [47, 48] .
Results
Rational design of mutagenesis sites in PCL
To determine whether and how the residues of PCL contribute to the activity effectively, a series of bioinformatic analyses were performed. Based on the analysis of the tertiary structure of PCL, only CBS I and CBS III adopt the QXDXNXVXY motif (X is one of the amino acid residues) conserved in GNA-related lectin. However, CBS II changed to HXNXNXVXY. The critical residues Gln58 and Asp60 of CBS II are substituted with His58 and Asn60. CBS II is unable to bind with mannose, but may bind with other types of sugars such as sialic acid as previously reported [49] . Moreover, it has been speculated that CBS I and CBS III maintain most of the carbohydrate-binding activity [23] . These facts suggest that the mannose affinity of PCL was lower than that of GNA and other mannose-binding lectins whose mannose-binding site does not mutate, such as GNA, CA, ASA, SCA, NHA, and CMA (Fig. 1A) .
Here, to investigate the effect of mutated CBS II and conservative CBS I and CBS III of PCL on the stability of structure and function, we designed the corresponding four mutants shown in Fig. 1B-F . The first variant was the reverse mutation of CBS II (mrPCL1-H58Q-N60D). The second variant was the selective mutation of CBS III (mrPCL2-N31V-Y35I). The third variant was the selective mutation of CBS I (mrPCL3-N94V-Y98I). Additionally, the fourth variant (mrPCL4-C30A-C53A) was constructed to investigate the effect of the two Cys (C30 and C53) on the structure of PCL.
Construction of the wrPCL and mutants expression system
Based on the total RNA, a 369 bp fragment containing the area encoding the mature peptide of PCL with 330 bases was obtained by PCR amplification using primers PE1 and PE2 ( Supplementary  Fig. S1A ). The sequence encoding the mature peptide of PCL was cloned to the expression vector pET32-a(+). Further, the mutants of PCL were obtained and cloned to the expression vector pET32-a(+). The insertion of PCL and mrPCL gene was confirmed by the digestion and colony PCR ( Supplementary Fig. S1B,C) . The bacterial colonies with recombinant plasmids were confirmed by western blot analysis using anti-His antibody ( Supplementary Fig. S1D ).
Expression and optimization of the expression conditions of wrPCL and mutants
The fusion proteins with His-tags were induced by IPTG, and the target proteins of mrPCL1 were released from the cells by sonication. The target proteins migrated at ∼29.7 kDa in SDS-PAGE. (Fig. 2A) . The optimization of expression conditions was carried out to improve the expression level of fusion proteins; mrPCL1-H58Q-N60D was taken as an example. Four different expression conditions including OD 600 , temperature, pH, and IPTG concentrations were optimized. Figure 2B shows that the optimal OD 600 was 0.6. The expression levels varied among different IPTG concentrations, and the results are shown in Fig. 2C . The expression quantity reached the highest value when the concentration of IPTG was about 0.5 mM. The optimum temperature for protein expression was 25°C (Fig. 2D) and the optimum pH was 7.2 ( Fig. 2E) . Finally, the expressed fusion protein accumulated up to about 38% of the total proteins of bacterial cells in the supernatant under the optimized conditions (OD 600 = 0.6, 25°C, 0.5 mM IPTG, pH 7.2).
Purification of wrPCL and mutants
After the cleavage and double purification, the eluents and enzyme solution were analyzed using 15% SDS-polyacrylamide gels (Fig. 2F) . About 15.6, 17.3, 17.7, 20.9, and 13.6 mg of wrPCL and mutants (mrPCL1, mrPCL2, mrPCL3, and mrPCL4) were obtained, respectively. Then, the active fractions were pooled and purified by using a CM-Sepharose FF column. The eluents of mrPCL1 were collected, and the active fractions were subject to 15% SDS-PAGE (Fig. 2F) . After the cleavage and purification, the wrPCL and mutant strains finally gave a single band as revealed by 15% SDS-PAGE (Fig. 2G) , corresponding to a molecular mass of ∼12.7 kDa as predicted by vector NTI 9.0.
Hemagglutinating and carbohydrate-binding activity of wrPCL and mutants
The restructuring protein of wrPCL and mutants can specifically agglutinate rabbit erythrocytes; the hemagglutinating activities of their purified products were measured. Only the mutant mrPCL1-H58Q-N60D was very similar to the wrPCL, with the minimal concentration of 1.95 μg/ml ( Table 1) , almost identical to that of rPCL (1.63 μg/ml). However, the hemagglutinating activity of other three mutants was completely lost. Furthermore, the carbohydrate-binding activities of wrPCL and mrPCL1 were determined by agglutination inhibition assay ( Table 2) . The carbohydrate-binding activity of mrPCL1 was also similar to that of wrPCL. In addition, among these tested sugars and glycoproteins, only mannoses, sialic acid, and thyroglobulin strongly inhibited the hemagglutinating activity of wrPCL and mrPCL1.
Effects of temperature and pH on the hemagglutinating activity of wrPCL and mrPCL1
Thermal stabilities of wrPCL and mrPCL1 were measured in the temperature range 20°C-100°C (Fig. 3A) . The trend of thermal and pH stability of mrPCL1 was almost the same as that of wrPCL; both wrPCL and mrPCL1 were fairly stable up to 40°C. Their hemagglutinating activities remained unchanged after incubation at 40°C for 20 min.
However, the hemagglutinating activities of wrPCL and mrPCL1 decreased to 88.9% and 77.8%, respectively, after incubation at 60°C. When exposed to 80°C, 33.3% of their hemagglutinating activity was still retained. The effects of pH on the hemagglutinating activity of wrPCL and mrPCL1 are shown in Fig. 3B . The hemagglutinating activity of wrPCL and mrPCL1 was almost completely maintained in the pH range 6-8. Although their activities gradually disappeared when the pH was above 8 or below 6, wrPCL and mrPCL1 maintained 33% activity at pH 2, whereas they became inactive at pH 12.
Fluorescence spectroscopy of wrPCL and mutants
The fluorescence emission spectra of wrPCL and mutants excited at 295 nm are shown in Fig. 3C . The endogenous fluorescence spectra of wrPCL and mutants showed two stages of changes after the mutation. Compared with the wrPCL and reverse mutant (mrPCL1-H58Q-N60D), the relative fluorescence intensity of the other three mutants was clearly decreased. Furthermore, a significant red shift of the emission spectra was observed in the other three mutants. The peak position of the wrPCL and the reverse mutant barely changed; they exhibited fluorescence emission maximum at 333 and 333.6 nm. However, the emission maximum were 347.2 , 345.2, and 345.6 nm for mrPCL4-C30A-C53A, mrPCL2-N31V-Y35I, and mrPCL3-N94V-Y98I, respectively. 
Bioinformatic analysis of wrPCL and mutants
MD trajectories analysis
To further validate contribution of structural changes in the mannose-binding activity of PCL, molecular docking and MD simulation were performed to explore the interactions between wrPCL (mrPCL) and mannose.
Root-mean-square deviation (RMSD) is a principal criterion used to evaluate the stability of a protein-ligand system in MD. It can be seen that the RMSD shows appreciably large differences among the various simulations (Fig. 4) . The RMSD values of wrPCL complexed with mannose ranged from 0 to 0.37 nm in the course of MD and attained an average RMSD values at 0.26 nm (2.6 Å). The CBS I of wrPCL complexes system remained more stable than other systems during simulation (Fig. 4A,D) . The CBS II and CBS III of wrPCL systems showed some trends or fluctuations in the time course of the RMSD. Their RMSD values fluctuated more than those of CBS I, and attained average RMSD values of 0.39 ± 0.10 nm (CBS II) and 0.40 ± 0.07 nm (CBS III), respectively (Fig. 4D) . Our analysis revealed that the CBS I was the main mannose binding site in wrPCL.
Moreover, RMSF can be used to evaluate the plasticity of each CBS of wrPCL-mannose; the deviation among the residues of wrPCL is shown in Fig. 5A . The 110 amino acid residues of CBS II and CBS III exhibited more fluctuation in wrPCL than those in CBS I. This indicated that only CBS I of wrPCL could bind with mannose stably, while CBS II and CBS III could not bind with mannose appropriately, which are consistent with previous structure analysis [23] .
As shown in Fig. 4B , the RMSD value of CBS I-mannose complex in mrPCL1 was comparable to that in wrPCL and attained an average value of 0.269 nm in the time course of RMSD. Its standard deviation of RMSD was 0.043 nm (Fig. 4D and Supplementary 
Data were obtained from three independent experiments, given as the mean. '-' Indicates the absence of activities of hemagglutinating. Table S2 ). Furthermore, the RMSF values of CBS I-mannose and CBS II-mannose in mrPCL1 ranged from 0.032 to 0.24 nm and showed similar trend compared with those in wrPCL (Fig. 5B) . However, the RMSD values of CBS I-mannose complex in other mutants were less stable and fluctuated more clearly than those of wrPCL-mannose complex during simulations. Particularly, the mrPCL2-mannose complex, as shown in Fig. 4C , was the most volatile complex. The RMSD values of mrPCL2-mannose complex attained an average RMSD value of 0.47 and the standard deviation of RMSD was 0.12 ( Fig. 4D) , which indicated that the simulations are not fully stable. The RMSF values of CBS I-mannose in mrPCL2 were less stable (Fig. 5C ).
As shown in Fig. 4B , D, the CBS II-mannose in mrPCL1 was less stable and did not change significantly compared with CBS II-mannose in wrPCL, but both fluctuated more drastically than CBS I-mannose in wrPCL and mrPCL1. The MD simulation further confirmed that the combination status of CBS II with mannose arising from the substitution of amino acid residue in CBS II had no significant change, and the CBS I of mrPCL1 could bind mannose and remained the hemagglutinating activity. The RMSD values of mrPCL3-mannose and mrPCL4-mannose fluctuated less than those of mrPCL2, but they fluctuated more distinctly than those of mrPCL1 and wrPCL (Fig. 4C,  D and Supplementary Table S2 ). The fluctuation of RMSF was consistent with previous analysis (Fig. 5C) . The 110 amino acid residues of mrPCL3-mannose and mrPCL4-mannose exhibited less fluctuation than those of mrPCL2, but they fluctuated more distinctly than those of mrPCL1 and wrPCL.
Binding affinity and mode analysis Here molecular docking and MM/PBSA calculation were performed to estimate the binding affinity of mannose complexed with PCL. The docking results based on Grid and Vina scores are shown in Table 3 . CBS I of wrPCL was found to bind mannose and formed hydrogen bonds involving Gln90 (O2, O3 in mannose), Asn94 (O2, O5 in mannose) and Tyr98 (O4 in mannose) of PCL (Supplementary Table S3 ). It showed hydrophobic interaction with Asp92 and high binding affinity with a Grid score of 32.12 kcal/mol and a Vina score of 3.1 kcal/ mol in CBS I of wrPCL. However, the CBS II of wrPCL Data represent mean values of relative hemagglutinating activity (%) from three independent experiments (mean). was unable to bind mannose with a Grid score of 26.49 kcal/mol and a Vina score of 2.3 kcal/mol. The CBS III of wrPCL was also unable to bind mannose with a Grid score of 30.22 kcal/mol and a Vina score of 2.9 kcal/ mol. The CBS II only had hydrophobic interaction with mannose. Asn31 of CBS III formed one hydrogen bond with mannose ( Table 3 and Fig. 6A) .
Nevertheless, the mutants of rPCL all had a lower affinity for mannose except mrPCL1 compared with wrPCL ( Table 3 and Fig. 7) . ΔΔG reflects the affinity change upon PCL mutation, which can be calculated by the formula: ΔΔG = ΔGmt−ΔGwt (mutation energy). The CBS I of mrPCL1 still maintained a high binding affinity and an obviously ascending trend with a Grid score ΔΔG 1 of −2.11 kcal/mol. The CBS II of mrPCL1 had a Grid score of −27.78 kcal/mol and a Vina score of −2.6 kcal/mol. The ΔΔG 1 (−1.29 kcal/ mol) and ΔΔG 2 (−0.3 kcal/mol) of CBS II in mrPCL1 were showed a smaller ascending tendency than those of CBS I. The CBS I of other three mutants had no binding affinity and showed a distinct descending tendency with mostly positive values of ΔΔG 1 and ΔΔG 2 ( Table 3) . The structure and binding mode analysis showed that the reverse mutation in mrPCL1 slightly increased the stability of CBS I of mrPCL1-mannose complex and the hydrogen bond interaction was almost the same as wrPCL. CBS I of mrPCL1 was found to bind with mannose and formed hydrogen bonds involving Gln90 (O2, O3 in mannose), Asn94 (O2, O5 in mannose) and Tyr98 (O4 in mannose) of PCL (Fig. 7A) . Then, the combination status of CBS II in mrPCL1 with mannose resulting from the substitution of amino acid residue in CBS II had no significant change (Fig. 7E,F) . However, the hydrogen bonds between CBS I of mrPCL2 and mannose disappeared completely, and only the hydrophobic interaction remained between them (Fig. 7B) . Moreover, the CBS I of mrPCL3 formed one hydrogen bond with mannose involving Ile97 (Fig. 7C) . Finally, CBS I could not form hydrogen bond Data were obtained from three independent experiments, and presented as the mean ± SD. '-' Indicates the absence of hemagglutinating activity. Supplementary Table S3. with mannose in mrPCL4, only hydrophobic interaction and other interactions remained between them (Fig. 7D) .
To further investigate the interactions between the mannose and mutants, the binding free energies were calculated using the MM/ GBSA method. The results of the predicted binding free energies and energy components of each complex are listed in Table 4 . The inter molecular van der Waals interactions (ΔEvdw) and electrostatic interactions (ΔEele) could be the driving force for the interactions between rPCL and mannose. Simultaneously, the binding free energy (ΔGbind) of mrPCL1-mannose (−11.92 kcal/mol) was slightly lower than that of wrPCL-mannose (−10.30 kcal/mol). The binding energy of mrPCL4 was −5.27 kcal/mol, relatively higher than that of wrPCL-mannose and mrPCL1-mannose. mrPCL2-mannose and mrPCL3-mannose had a binding energy of −2.59 and −3.55 kcal/mol, ranked at the third and fourth places.
Discussion
PCL, a member of GNA-related lectin family, was extracted and purified from the rhizomes of Polygonatum cyrtonema Hua, a traditional Chinese herbal medicine. Over the years, it has attracted increasing attention mainly because of its considerable antitumor and antiviral activities. Compared with other mannose-binding lectins such as NA, CA, ASA, and SCA, PCL has only two typical carbohydrate-binding sites (QDNVY). In CBS II, it changed to HNNVY, the residues Gln58 and Asp60 were mutated to His58 and Asn60, respectively [50] . Based on the crystal structure and multiple alignment with other lectins, four mutants (mrPCL1-H58Q-N60D, mrPCL2-N31V-Y35I, mrPCL3-N94V-Y98I, and mrPCL4-C30A-C53A) were selected to gain further insight into the structural stability and biological activity of PCL. The results showed that individual carbohydrate-binding domain and key amino acids play a vital role in the function and structure. Compared with the wrPCL, only mrPCL1 maintained similar haemagglutinating and carbohydratebinding activity. The wrPCL and mrPCL1 exerted hemagglutinating activities toward rabbit blood erythrocytes with a minimum concentration of 1.95 and 1.63 μg/ml, similar to those reported in a previous study [49] . Furthermore, the carbohydrate-binding activity of mrPCL1 is also similar to that of wrPCL. Apparently, the hemagglutinating activity and carbohydrate-binding activity of mrPCL1 showed no significant change after the mutation, suggesting that the Q (Gln) and D (Asp) of CBS II do not play an important role in carbohydrate binding. However, other three mutants completely lost their hemagglutinating activity. mrPCL2-N31V-Y35I was the amino acid substitution of CBS III, and mrPCL3-N94V-Y98I was the amino acid substitution of CBS I. The deactivation of the two mutants showed that the two carbohydrates-binding sites play a vital role in mannose binding. According to previous study, only CBS I can bind with mannose. Therefore, although the most critical domain was CBS I in binding with mannose, CBS III was also indispensable. CBS III may play a supplementary role and maintain the normal structure of PCL. Furthermore, Cys30 and Cys53 were conservative in all MBL, the inactivation of mrPCL4-C30A-C53A indicated that the disulfide bond was the crucial secondary structure to maintain the stable 3D structure of PCL. Moreover, from the perspective of fluorescence, the emission peaks of the three mutants (mrPCL2, mrPCL3, and mrPCL4) with lost activity showed a red shift compared to that of wrPCL. This observation confirmed that the Trp residues of the three mutants are located in a less hydrophobic environment and their structures are quite loose. Moreover, this also indicated that the mutations induced Trp residues to expose to the surface of the molecule and destroyed the conformation and activity of PCL [51] . Nevertheless, mrPCL1 maintained normal hemagglutinating activity and carbohydrate-binding specificity. This result highlights the dispensable role of His58 and Asn60 in the carbohydrate binding of PCL and the crucial role of CBS I, CBS III, and disulfide bond.
To provide more accurate and further evidence, docking and MD simulations were conducted. The docking results based on Grid Score and Vina Score show that only CBS I with the best score can bind with mannose in wrPCL. However, CBS II and CBS III with poor scores could not bind with mannose. This result is consistent with what was reported in a previous study [50] . The ΔΔG1 and ΔΔG2 reflect the affinity of the binding of CBS I of mutants. The binding activity of mrPCL1 with mannose was more tightly than wrPCL. Unlike the mrPCL1, the binding activity of mrPCL2, mrPCL3, and mrPCL4 with mannose was more loosely than wrPCL. Simultaneously, the five hydrogen bonds between mannose and CBS I can also constrain the deduction. Although it is not an actual binding condition, we simulated the binding condition between CBS II/CBS III and mannose in wrPCL to investigate the binding situation. The results showed that the carbohydrate-binding activity of reverse mutant (mrPCL1) was completely destroyed. No hydrogen bonds were observed between mannose and CBS II. In the other three mutations, the hydrogen bonds between CBS I and mannose were decreased or destroyed. Mannose only interacts with some other residues of CBS I through hydrophobic and van der Waals interactions. Apparently, the CBS I of the three mutations was incapable of binding with mannose. The MD results were consistent with the docking results. The low fluctuation of RMSD and RMSF values showed that only the CBS I of wrPCL and mrPCL1 had the closest and most stable binding with mannose. Moreover, by analyzing the structural characteristics of QDNVY box, Asn (N) and Tyr (Y) were moderately polar amino acids in mrPCL2 and mrPCL3 substituted with Val (V) and Ile (I) which was moderately nonpolar amino acids. This indicates that the carbohydrate-binding site of PCL may be in a hydrophilic environment. Substitutions of amino acids resulting in a hydrophobic environment will directly destroy the activity of mutants.
Overall, we successfully induced and purified wrPCL and its mutants from a pET expression system under the optimal conditions. The activity and carbohydrate-binding of mutants showed that the two carbohydrates-binding sites (CBS I and CBS III) and disulfide bond played vital roles in the binding with mannose. Although the most critical domain for mannose binding is CBS I, CBS III and disulfide bond are also indispensable and may play an auxiliary role in maintaining the activity and 3D structure. The CBS II, Gln (Q) and Asp (D) of CBS II do not play a critical role in the model for mannose binding by PCL. The results of fluorescence spectrum provided further proof. Molecular docking and MD analysis agrees well with above study. In addition, the carbohydratebinding site of PCL may be in a hydrophilic environment. Mannose only interacts with some other residues of the CBS I mainly through hydrophobic and van der Waals contacts. Asn (N) and Tyr (Y) are the key amino acid residues for the binding with mannose. The methods of our comprehensive research can provide certain reference for similar studies. Moreover, our research may lay a foundation for the future development of PCL into an anticancer or antiviral drug.
Supplementary Data
Supplementary data is available at Acta Biochimica et Biophysica Sinica online. Components: ΔEvdw, van der Waals energy contribution from MM; ΔEele, electrostatic energy in the gas phase as calculated by the MM force field; ΔGgb, the electrostatic solvation energy (e.g. polar contribution); ΔGsa, nonelectrostatic solvation energy (e.g. nonpolar contribution). ΔGbind, the final estimated relative binding free energy calculated from all terms mentioned above and estimated as following: ΔGbind = ΔGgas + ΔGsolv; ΔGgas = ΔEele + ΔEvdw; ΔGsolv = ΔGgb + ΔGsa.
